Australia markets closed

CVS Health Corporation (CVS.MX)

Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
935.25-234.75 (-20.06%)
At close: 01:56PM CST
Currency in MXN

Valuation measures4

Market cap (intra-day) 1.17T
Enterprise value 2.34T
Trailing P/E 9.68
Forward P/E 6.72
PEG ratio (5-yr expected) 1.22
Price/sales (ttm)0.20
Price/book (mrq)0.94
Enterprise value/revenue 6.48
Enterprise value/EBITDA 136.30

Trading information

Stock price history

Beta (5Y monthly) 0.51
52-week change 3-4.24%
S&P500 52-week change 321.33%
52-week high 31,400.00
52-week low 3910.00
50-day moving average 31,246.57
200-day moving average 31,248.15

Share statistics

Avg vol (3-month) 3562
Avg vol (10-day) 3231
Shares outstanding 51.26B
Implied shares outstanding 61.26B
Float 81.25B
% held by insiders 10.12%
% held by institutions 182.53%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 445.63
Forward annual dividend yield 44.88%
Trailing annual dividend rate 32.48
Trailing annual dividend yield 30.21%
5-year average dividend yield 42.91
Payout ratio 443.51%
Dividend date 3N/A
Ex-dividend date 419 Apr 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 2.04%
Operating margin (ttm)2.07%

Management effectiveness

Return on assets (ttm)3.18%
Return on equity (ttm)10.09%

Income statement

Revenue (ttm)359.66B
Revenue per share (ttm)281.15
Quarterly revenue growth (yoy)3.60%
Gross profit (ttm)N/A
EBITDA 16.93B
Net income avi to common (ttm)7.32B
Diluted EPS (ttm)96.70
Quarterly earnings growth (yoy)-47.90%

Balance sheet

Total cash (mrq)13.09B
Total cash per share (mrq)10.43
Total debt (mrq)81.79B
Total debt/equity (mrq)110.31%
Current ratio (mrq)0.81
Book value per share (mrq)59.08

Cash flow statement

Operating cash flow (ttm)10.89B
Levered free cash flow (ttm)8.37B